Neos Therapeutics (NEOS) Prices 4.8M Common Stock IPO at $15/Share, at Middle of Range
Get Alerts NEOS Hot Sheet
Join SI Premium – FREE
Neos Therapeutics, Inc. ("Neos" or "the Company") (Nasdaq: NEOS) announced the pricing of its initial public offering of 4,800,000 shares of common stock at an initial public offering price of $15.00 per share. In addition, Neos has granted the underwriters a 30-day option to purchase up to an additional 720,000 shares of common stock at the initial public offering price. The shares of Neos' common stock are expected to begin trading on the NASDAQ Global Market on July 23, 2015 under the ticker symbol "NEOS." The offering is expected to close on July 28, 2015, subject to customary closing conditions.
*** The company recently expected a pricing range of $14 to $16 per share.
UBS Investment Bank, BMO Capital Markets and RBC Capital Markets are acting as joint book-running managers and JMP Securities is acting as a lead manager for the offering.
- See more at: http://globenewswire.com/news-release/2015/07/23/754481/10142831/en/Neos-Therapeutics-Announces-Pricing-of-Initial-Public-Offering.html#sthash.vNNkqbC2.dpuf
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U-BX Technology (UBXG) IPO Opens At $5, Priced at $5
- IMMRSIV (IMSV) Announces 4.14M Share IPO at $4-$5/sh
- Dyadic International, Inc. (DYAI) Announces Board and Management Changes
Create E-mail Alert Related Categories
Corporate News, Hot Corp. News, IPOsRelated Entities
UBS, BMO Capital, RBC Capital, JMP Securities, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!